Literature DB >> 22246900

Prognosis for primary retroperitoneal sarcoma survivors: a conditional survival analysis.

Andrea M Abbott1, Elizabeth B Habermann, Helen M Parsons, Todd Tuttle, Waddah Al-Refaie.   

Abstract

BACKGROUND: The AJCC staging system and post-operative nomograms use patient and tumor characteristics to provide prognostic estimates after resection of retroperitoneal sarcoma (RPS). While these variables help to predict survival at the time of diagnosis and resection, the applicability of these prognostic factors to survivors of RPS remains unknown. We hypothesized that the variables evaluated in the current staging system and post-operative nomograms would have limited ability to predict conditional survival in patients surgically treated for RPS.
METHODS: A retrospective study was conducted using National Cancer Institute-sponsored tumor registries. We identified 1,199 patients who underwent surgical resection for non-metastatic RPS from 1988 to 2007. Conditional survival was defined as time-specific estimates conditioned on living a certain number of years post-diagnosis. Cox proportional hazards regression was used to assess the impact of various factors on sarcoma-specific survival (SSS) at baseline and up to 5 years after diagnosis.
RESULTS: Older age, male gender, histologic subtype, and high tumor grade predicted worse SSS at the time of diagnosis. After 1 year of survival, older age, male gender, and histologic subtype were no longer significant predictors of conditional survival. Only high grade tumors remained a significant predictor of worse prognosis after 5 years of survival (HR 1.95).
CONCLUSIONS: This population-based study demonstrates that the factors which are predictive of survival at baseline lose significance after one year of survival. Conditional survival estimates allow clinicians to provide survivors with more meaningful prognostic estimates that may impact surveillance schedules and streamline adjuvant therapy decisions and design of future clinical trials.
Copyright © 2012 American Cancer Society.

Entities:  

Mesh:

Year:  2012        PMID: 22246900     DOI: 10.1002/cncr.26665

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Resection of retroperitoneal sarcoma en-bloc with inferior vena cava: 20 year outcomes of a single institution.

Authors:  Alex B Blair; Bradley N Reames; Jasvinder Singh; Faiz Gani; Heidi N Overton; Robert J Beaulieu; Ying W Lum; James H Black; Fabian M Johnston; Nita Ahuja
Journal:  J Surg Oncol       Date:  2018-06-07       Impact factor: 3.454

2.  Preoperative Biopsy in Patients with Retroperitoneal Sarcoma: Usage and Outcomes in a National Cohort.

Authors:  Richard J Straker; Yun Song; Adrienne B Shannon; Clayton T Marcinak; John T Miura; Douglas L Fraker; Giorgos C Karakousis
Journal:  Ann Surg Oncol       Date:  2021-02-16       Impact factor: 5.344

3.  Histology-based Classification Predicts Pattern of Recurrence and Improves Risk Stratification in Primary Retroperitoneal Sarcoma.

Authors:  Marcus C B Tan; Murray F Brennan; Deborah Kuk; Narasimhan P Agaram; Cristina R Antonescu; Li-Xuan Qin; Nicole Moraco; Aimee M Crago; Samuel Singer
Journal:  Ann Surg       Date:  2016-03       Impact factor: 12.969

Review 4.  Surgical management of retroperitoneal and pelvic sarcomas.

Authors:  Marcus C B Tan; Sam S Yoon
Journal:  J Surg Oncol       Date:  2014-12-05       Impact factor: 3.454

5.  Characteristics and computed tomography evaluation of primary retroperitoneal tumours: report of 113 cases.

Authors:  W Cheng; Y Qi; B Wang; L Tian; W Huang; Y Chen
Journal:  Ann R Coll Surg Engl       Date:  2016-08-11       Impact factor: 1.891

6.  Prognostic significance of early recurrence: a conditional survival analysis in patients with resected colorectal liver metastasis.

Authors:  Marcus C B Tan; Jean M Butte; Mithat Gonen; Nancy Kemeny; Yuman Fong; Peter J Allen; T Peter Kingham; Ronald P Dematteo; William R Jarnagin; Michael I D'Angelica
Journal:  HPB (Oxford)       Date:  2013-06-19       Impact factor: 3.647

7.  Evaluating the Impact of Surveillance Follow-Up Intervals in Patients Following Resection of Primary Well-Differentiated Liposarcoma of the Retroperitoneum.

Authors:  Emily Z Keung; Nikita Rajkot; Keila E Torres; Neeta Somaiah; Kelly K Hunt; Barry W Feig; Christopher P Scally; Naruhiko Ikoma; Christina L Roland
Journal:  Ann Surg Oncol       Date:  2020-05-14       Impact factor: 5.344

8.  Conditional survival for longer-term survivors from 2000-2004 using population-based cancer registry data in Osaka, Japan.

Authors:  Yuri Ito; Tomio Nakayama; Isao Miyashiro; Akiko Ioka; Hideaki Tsukuma
Journal:  BMC Cancer       Date:  2013-06-22       Impact factor: 4.430

9.  Percutaneous computed tomography-guided cryoablation for recurrent retroperitoneal soft tissue sarcoma: a study of safety and efficacy.

Authors:  Wenzhe Fan; Lizhi Niu; Yu Wang; Yingqiang Zhang; Xuehua Yao; Guosheng Tan; Jianyong Yang; Jiaping Li
Journal:  Oncotarget       Date:  2016-07-05

10.  Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors.

Authors:  Dario Callegaro; Rosalba Miceli; Sylvie Bonvalot; Peter C Ferguson; Dirk C Strauss; Veroniek V M van Praag; Antonin Levy; Anthony M Griffin; Andrew J Hayes; Silvia Stacchiotti; Cecile Le Pèchoux; Myles J Smith; Marco Fiore; Angelo Paolo Dei Tos; Henry G Smith; Charles Catton; Joanna Szkandera; Andreas Leithner; Michiel A J van de Sande; Paolo G Casali; Jay S Wunder; Alessandro Gronchi
Journal:  EClinicalMedicine       Date:  2019-11-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.